Affimed (Nasdaq: AFMD) is a clinical stage biopharmaceutical company which engineers targeted immunotherapies, seeking to improve patient outcomes through the power of innate immunity. Affimed’s fit-for-purpose ROCK® platform allows innate immune engagers to be designed for specific patient populations. We are developing single and combination therapies to treat cancers.
To strengthen our highly motivated Research & Development Team in Heidelberg, Germany, we are looking for a
(Reference No. R2211)
to support preclinical development of novel biologics in immuno-oncology.
The successful candidate will have the unique opportunity to work in a dynamic, highly motivated, multidisciplinary, and collegial team incl. a flexibility for home office solutions.
For any queries, please contact Susanne Hering (Tel: 06221 6743 675, e-mail: email@example.com).